Confidentiality disclosure agreements (CDAs) are signed by the institution, so faculty are not able to sign one on their own. We recommend that before agreeing to a CDA you learn more about the company and how a CDA may impact your research going forward. Industry Engagement can help you determine the goals of the CDA, decide on next steps and help you navigate the CDA process if you do decide to move forward. Learn more about CDAs and BU’s process below.

Initiating the Process

If you think you may need a CDA or if you have received a CDA from a company, please complete the CDA Request Form. Your completed form will be assigned to the appropriate representative from Industry Engagement or Technology Development.

Boston University processes CDAs for University business only. The CDA is executed by and between the University and the third party and not in the name of any individual. This form is not intended for use with personal matters, including personal consulting arrangements.

CDA Request Form

 

What’s a confidentiality agreement?

Confidentiality disclosure agreements (CDAs) or nondisclosure agreements (NDAs) protect information disclosed in the course of evaluating a possible business relationship that is not yet in the public domain by limiting further disclosure and use by the recipient. There are three general forms of the agreement:

  • one-way transfer of information from the university out to a third-party
  • one-way transfer of information from a third-party to the university
  • two-way transfer of information between the university and a third-party (i.e., both parties share confidential information)

Bearing in mind that the University is a fairly open environment and that maintaining another’s confidentiality is an obligation you will undertake to the benefit and potential detriment of yourself and the University, the correct agreement should be judiciously selected for the particular circumstances of the contemplated transaction.

Balancing Open Exchanges and CDAs

As an academic institution it is important to preserve our right to publish and openly exchange information. The receipt of confidential information can potentially limit academic freedom if not managed properly.

You should avoid accepting any more information from a third party than is absolutely necessary. If you do not need a third party’s confidential information, the agreement should be a one-way transfer of information to the third party. If it is at all possible to accomplish your goals without the transfer of confidential information, you are encouraged to pursue that option and thereby avoid unnecessary entanglements or restrictions on your research.

Remember that when you receive third party information, you are not only obligated to maintain it in a confidential manner, but you also cannot use the information outside the context of the contemplated transaction. That can be difficult to control in an academic environment and this should be an important factor when you elect to enter into a transaction requiring a CDA.

We prefer to limit the obligations of confidentiality and non-use to short periods of time—usually two to three years. In general, periods of confidentiality and non-use exceeding five years will only be acceptable in rare situations and will require sound justification.

Why have a CDA at all?

Given the general concerns, why have CDAs at all? If we do not want to receive confidential information and we do not keep confidential information for long periods, then Confidentiality Agreements do not make much sense. In fact, it is very possible to have constructive discussions with third parties without revealing confidential information – for example discussing the performance of a material but not revealing its structure/composition. An effective non-confidential description of your work is usually the best starting place.

There are circumstances when a CDA makes sense and CDAs protect BU and BU investigators in several ways:

  • They allow BU investigators to discuss interesting new findings without compromising their future patentability.
  • They memorialize what was discussed between the investigator and the company, so that if later there are questions about who originally developed an idea, we have a record of when the discussion took place.
  • A CDA allows BU researchers to review and share company data or protocols with other BU employees to better evaluate opportunities for collaboration.

Examples of times when a CDA is useful:

  • You have key data available prior to filing a patent application or submitting a manuscript that you would like to share in a limited way.
  • Industry sponsors will often ask BU to sign a CDA as a precursor to a sponsor-initiated clinical trial or sponsored research project.

If you think you need a CDA, please contact Industry Engagement for exchanges related to research collaborations or Technology Development for exchanges related to licensing intellectual property to discuss the best path forward.